Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltrombopag and Dexamethasone in First-Line ITP
NCT01652599Phase 2Completed
- Sponsor
- Hospital Universitario Dr. Jose E. Gonzalez
- Start
- Jun 2012
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eltrombopag in immune thrombocytopenia (ITP), sponsored by Hospital Universitario Dr. Jose E. Gonzalez. Started Jun 2012; status: completed.
02
Drugs
eltrombopag
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT01652599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01652599.